DNA METHYLATION-BASED SUBCLASS PREDICTS THE EFFECT OF THE EXTENT OF RESECTION ON SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA

被引：0
|
作者：
Dankmeijer, L. G. [1 ,2 ]
Westerink, L. G. [1 ,2 ]
Hamer, P. C. de Witt [1 ,2 ]
Wesseling, P. [3 ,4 ]
Kouwenhoven, M. C. M. [5 ]
Kooi, E. [3 ]
Verburg, N. [1 ,2 ]
机构：
[1] Amsterdam UMC, Locat VUmc, Dept Neurosurg, Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Brain Tumor Ctr, Amsterdam, Netherlands
[3] Amsterdam UMC, Locat VUmc, Dept Pathol, Amsterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Pathol, Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[5] Amsterdam UMC, Locat VUmc, Dept Neurol, Amsterdam, Netherlands
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11.47.B
引用
收藏
页数：1
相关论文
共 50 条
  • [31] TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype
    Di Nunno, Vincenzo
    Gatto, Lidia
    Tosoni, Alicia
    Aprile, Marta
    Galvani, Linda
    Zappi, Arianna
    Foschini, Maria Pia
    Asioli, Sofia
    Tallini, Giovanni
    De Biase, Dario
    Maloberti, Thais
    Bartolini, Stefania
    Giannini, Caterina
    Franceschi, Enrico
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [32] LONG-TERM SURVIVAL AND MOLECULAR CHARACTERIZATION OF IDH-WILDTYPE GLIOBLASTOMA IN AN ASIAN COHORT
    Lee, Wing Lun
    Ko, Elaine Yee-Ling
    Lecoultre, Marc
    Ho, Isaac
    Chiu, Matthew Kin-liang
    Chiang, Chi-Leung
    Leung, Dennis
    Leung, Gilberto Ka-Kit
    Chow, Joyce Shuk-wan
    Woo, Peter Yat Ming
    Lam, Tai Chung
    Aya, El Helali
    NEURO-ONCOLOGY, 2024, 26
  • [33] Incorporating Supramaximal Resection into Survival Stratification of IDH-wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis
    Park, Yae Won
    Choi, Kyu Sung
    Foltyn-Dumitru, Martha
    Brugnara, Gianluca
    Banan, Rouzbeh
    Kim, Sooyon
    Han, Kyunghwa
    Park, Ji Eun
    Kessler, Tobias
    Bendszus, Martin
    Krieg, Sandro
    Wick, Wolfgang
    Sahm, Felix
    Choi, Seung Hong
    Kim, Ho Sung
    Chang, Jong Hee
    Kim, Se Hoon
    Wongsawaeng, Doonyaporn
    Pollock, Jeffrey Michael
    Lee, Seung-Koo
    Barajas, Ramon Francisco
    Vollmuth, Philipp
    Ahn, Sung Soo
    CLINICAL CANCER RESEARCH, 2024, 30 (21) : 4866 - 4875
  • [34] Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients
    Hallaert, Giorgio
    Pinson, Harry
    Vanhauwaert, Dimitri
    Van den Broecke, Caroline
    Van Roost, Dirk
    Boterberg, Tom
    Kalala, Jean-Pierre
    SURGICAL ONCOLOGY-OXFORD, 2020, 35 : 515 - 519
  • [35] Sex-based survival differences in IDH-wildtype glioblastoma: Results from a retrospective cohort study
    Hallaert, G.
    Pinson, H.
    Van den Broecke, C.
    Van Roost, D.
    Kalala, J. P.
    Boterberg, T.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 91 : 209 - 213
  • [36] Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics
    Georges Chehade
    Tévi Morel Lawson
    Julie Lelotte
    Lina Daoud
    Dario Di Perri
    Nicolas Whenham
    Thierry Duprez
    Nicolas Tajeddine
    Fadel Tissir
    Christian Raftopoulos
    Acta Neurochirurgica, 2023, 165 : 1075 - 1085
  • [37] SURVIVAL STRATIFICATION OF IDH-WILDTYPE GLIOBLASTOMA IN THE MOLECULAR ERA: A RECURSIVE PARTITIONING ANALYSIS INCORPORATING EXTENT OF RESECTION OF CONTRAST-ENHANCING AND NON-ENHANCING TUMORS
    Park, Yae Won
    Choi, Kyu Sung
    Park, Ji Eun
    Ahn, Sung Soo
    Chang, Jong Hee
    NEURO-ONCOLOGY, 2023, 25
  • [38] Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics
    Chehade, Georges
    Lawson, Tevi Morel
    Lelotte, Julie
    Daoud, Lina
    Di Perri, Dario
    Whenham, Nicolas
    Duprez, Thierry
    Tajeddine, Nicolas
    Tissir, Fadel
    Raftopoulos, Christian
    ACTA NEUROCHIRURGICA, 2023, 165 (04) : 1075 - 1085
  • [39] Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
    Teske, Nico
    Karschnia, Philipp
    Weller, Jonathan
    Siller, Sebastian
    Dorostkar, Mario M.
    Herms, Jochen
    von Baumgarten, Louisa
    Tonn, Joerg Christian
    Thon, Niklas
    JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (02) : 317 - 327
  • [40] Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
    Nico Teske
    Philipp Karschnia
    Jonathan Weller
    Sebastian Siller
    Mario M. Dorostkar
    Jochen Herms
    Louisa von Baumgarten
    Joerg Christian Tonn
    Niklas Thon
    Journal of Neuro-Oncology, 2022, 156 : 317 - 327
12345